Eupraxia Pharmaceuticals's total assets for Q3 2023 were C$34.35M, an increase of 68.79% from the previous quarter. EPRX total liabilities were C$19.29M for the fiscal quarter, a 31.58% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.